Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial

Georgios J. Vlachojannis1, MD, PhD; Pieter C. Smits1*, MD, PhD; Sjoerd H. Hofma2, MD, PhD; Mario Togni3, MD; Nicolás Vázquez4, MD; Mariano Valdés5, MD; Vassilis Voudris6, MD; Serban Puricel3, MD; Ton Slagboom7, MD; Jean-Jacques Goy3, MD; Peter den Heijer8, MD, PhD; Martin van der Ent1, MD, PhD

1. Department of Cardiology, Maasstad Hospital, Rotterdam, The Netherlands; 2. Department of Cardiology, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands; 3. Department of Cardiology, Hôpital Cantonal de Fribourg, Fribourg, Switzerland; 4. Departme

Aims: The aim of this analysis was to compare the long-term safety and efficacy of the biodegradable polymer biolimus-eluting stent (BES) with that of the durable polymer everolimus-eluti

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

biodegradable polymerbiolimus-eluting stenteverolimus-eluting stentnoboripromusxience

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry